Abcam, ab141331, Clofibrate, PPARalpha agonist

Size: 1g / 5g
MW 242.7 Da, Purity >99%. PPARα agonist (EC 50 values are 50 and 55 μM at mouse and human receptors respectively). Antihyperlipoproteinemic agent.
Key facts
CAS number:637-07-0,
Purity:>99%,
Form:LiquidSee storage information,
Molecular weight:242.7 Da,
Molecular formula:C12H15ClO3,
PubChem:2796,
Nature:Synthetic,
Biochemical name:Clofibrate,
Biological description:PPARα agonist (EC50 values are 50 and 55 μM at mouse and human receptors respectively). Antihyperlipoproteinemic agent.,
Canonical smiles:CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,
InChi:InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3,
InChiKey:KNHUKKLJHYUCFP-UHFFFAOYSA-N,
IUPAC Name:ethyl 2-(4-chlorophenoxy)-2-methylpropanoate

Product details:
ab141331 is a colorless liquid at room temperature with a density of approximately 1.1 g/mL.

Properties and Storage Information:
Shipped at conditions-Ambient - Can Ship with Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
The Estrogen Receptor Cytochrome P450 3A4 (CYP3A4) and liver FABP (Fatty Acid Binding Protein) are important proteins with distinct mechanical roles in the body. The Estrogen Receptor acts as a nuclear hormone receptor regulating gene expression upon estrogen binding. CYP3A4 a member of the cytochrome P450 family is a large enzyme with a mass of approximately 57 kDa and is mainly expressed in the liver. It functions to metabolize various xenobiotics and endogenous compounds. The liver FABP a smaller protein helps bind and transport fatty acids within liver cells.
Biological function summary
The Estrogen Receptor influences reproductive tissues and breast development by regulating genes involved in cell growth. It forms complexes with coactivator proteins to modulate transcription. CYP3A4 participates in the metabolism of drugs and steroids affecting their clearance and bioavailability. Liver FABP assists in the intracellular trafficking of lipids and the modulation of lipid levels within hepatocytes which are liver cells.
Pathways
The Estrogen Receptor plays significant roles in the estrogen signaling pathway which involves proteins like coactivators and corepressors influencing cell proliferation and differentiation. CYP3A4 facilitates the drug metabolism pathway interacting with proteins such as cytochrome P450 reductase. These proteins collaborate to metabolize drugs and regulate endogenous steroid levels. Liver FABP is involved in lipid metabolism pathways working with enzymes that process and transport lipids within the liver.
Estrogen Receptor dysfunction relates to hormone-sensitive cancers such as breast cancer. This receptor's interaction with proteins like HER2 impacts tumor progression and response to therapy. CYP3A4 is associated with drug metabolism disorders leading to altered pharmacokinetics and may affect proteins involved in drug clearance increasing susceptibility to drug toxicity. Liver FABP plays a role in fatty liver disease with its interaction affecting lipid metabolism pathways and gene expression in metabolic disorders.